Elevation Oncology (NASDAQ:ELEV) Price Target Cut to $1.00 by Analysts at HC Wainwright
Elevation Oncology (NASDAQ:ELEV – Free Report) had its price objective trimmed by HC Wainwright from $6.00 to $1.00 in a ...
Q1 Earnings Forecast for AVTX Issued By HC Wainwright
HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Avalo Therapeutics in a research report issued to ...